Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

06/03/2026

Dirigenti II Fascia - aggiornamento sezione

Ultime notizie

30/01/2026

Uso di benzodiazepine e antipsicotici nelle persone con demenza

Biblioteca Virtuale per la Salute – Piemonte

27/02/2026

Newsletter Promozione della Salute – Dors, febbraio 2026

Agendas and minutes

06/03/2026

Minutes of the HMPC meeting 19-21 January 2026

Consumer Updates RSS Feed

13/02/2026

Drugs

Regulatory and procedural guidelines (human and veterinary)

27/02/2026

List of centrally authorised products with safety-related changes to the product information

Scientific guidelines (human and veterinary)

06/03/2026

EU implementation strategy of ICH E2D(R1) Guideline - Post-approval safety data: Definitions and standards for management and reporting of individual case safety reports

Paediatric investigation plans

06/03/2026

Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: EMA/PE/0000222532

New medicines and opinions: human

27/02/2026

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Status: Opinion

MedWatch Safety Alerts RSS Feed

06/03/2026

Wound and Burn Dressing Recall: Integra LifeSciences Removes Certain MediHoney and CVS Wound and Burn Products

What's New: Drugs RSS Feed

06/03/2026

Section 804 Importation Program Policies and Authorizations

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis